116 related articles for article (PubMed ID: 36115333)
21. Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
Zou C; Huang D; Wei H; Wu S; Song J; Tang Z; Li X; Ai Y
J Immunol Res; 2021; 2021():6203759. PubMed ID: 34497859
[TBL] [Abstract][Full Text] [Related]
22. Lipid Droplet-Related PLIN2 in CD68
He Y; Dong Y; Zhang X; Ding Z; Song Y; Huang X; Chen S; Wang Z; Ni Y; Ding L
Front Oncol; 2022; 12():824235. PubMed ID: 35372038
[TBL] [Abstract][Full Text] [Related]
23. Identification of Potential Molecular Mechanisms and Prognostic Markers for Oral Squamous Cell Carcinoma: A Bioinformatics Analysis.
Chujan S; Kitkumthorn N; Satayavivad J
J Int Soc Prev Community Dent; 2023; 13(3):237-246. PubMed ID: 37564170
[TBL] [Abstract][Full Text] [Related]
24. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells.
Zhou L; Li H; Cai H; Liu W; Pan E; Yu D; He S
Front Oncol; 2022; 12():809589. PubMed ID: 35299748
[TBL] [Abstract][Full Text] [Related]
26. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with
Hsieh YP; Wu YH; Cheng SM; Lin FK; Hwang DY; Jiang SS; Chen KC; Chen MY; Chiang WF; Liu KJ; Huynh NC; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563222
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
28. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
29. CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm.
Yao S; Huang Z; Wei C; Wang Y; Xiao H; Chen S; Huang Z
BMC Oral Health; 2023 Jun; 23(1):411. PubMed ID: 37344840
[TBL] [Abstract][Full Text] [Related]
30. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Raghunandan BN; Sanjai K; Kumaraswamy J; Papaiah L; Pandey B; Jyothi BM
J Oral Maxillofac Pathol; 2016; 20(1):96-101. PubMed ID: 27194869
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of VAP-1 in OSCC suppresses tumor growth and metastasis via NF-κB/IL-8 signaling and reduces neutrophil infiltration.
Xu Q; Chen X; Yu T; Tang Q; Zhou Z; Wang H; Huang W; Huang T; Liang F
J Oral Pathol Med; 2022 Apr; 51(4):332-341. PubMed ID: 35174543
[TBL] [Abstract][Full Text] [Related]
32. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
[TBL] [Abstract][Full Text] [Related]
33. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
34. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.
Parikh A; Shin J; Faquin W; Lin DT; Tirosh I; Sunwoo JB; Puram SV
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958684
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
36. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma.
Wu JE; Li Y; Hou J
J Cell Mol Med; 2023 Nov; 28(5):e18010. PubMed ID: 37927242
[TBL] [Abstract][Full Text] [Related]
39. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
40. [Effect of
Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
